119 related articles for article (PubMed ID: 25869398)
1. Activin-βC modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice.
Marino FE; Risbridger G; Gold E
Mol Cell Endocrinol; 2015 Jul; 409():41-50. PubMed ID: 25869398
[TBL] [Abstract][Full Text] [Related]
2. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
Marino FE; Risbridger G; Gold E
Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
[TBL] [Abstract][Full Text] [Related]
3. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
[TBL] [Abstract][Full Text] [Related]
4. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
Cipriano SC; Chen L; Kumar TR; Matzuk MM
Endocrinology; 2000 Jul; 141(7):2319-27. PubMed ID: 10875231
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
Elmoneim HM; Samaka RM; Ali H
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):462-9. PubMed ID: 22417854
[TBL] [Abstract][Full Text] [Related]
7. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
Beuschlein F; Looyenga BD; Bleasdale SE; Mutch C; Bavers DL; Parlow AF; Nilson JH; Hammer GD
Mol Cell Biol; 2003 Jun; 23(11):3951-64. PubMed ID: 12748296
[TBL] [Abstract][Full Text] [Related]
8. Role of androgens in testicular tumor development in inhibin-deficient mice.
Shou W; Woodruff TK; Matzuk MM
Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
[TBL] [Abstract][Full Text] [Related]
9. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex.
Looyenga BD; Hammer GD
Mol Endocrinol; 2006 Nov; 20(11):2848-63. PubMed ID: 16873442
[TBL] [Abstract][Full Text] [Related]
10. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
Coerver KA; Woodruff TK; Finegold MJ; Mather J; Bradley A; Matzuk MM
Mol Endocrinol; 1996 May; 10(5):534-43. PubMed ID: 8732684
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
12. Activin-βC modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways.
Marino FE; Risbridger G; Gold E
J Cachexia Sarcopenia Muscle; 2015 Dec; 6(4):365-80. PubMed ID: 26673867
[TBL] [Abstract][Full Text] [Related]
13. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.
Kananen K; Markkula M; Mikola M; Rainio EM; McNeilly A; Huhtaniemi I
Mol Endocrinol; 1996 Dec; 10(12):1667-77. PubMed ID: 8961275
[TBL] [Abstract][Full Text] [Related]
14. Inhibin and p27 interact to regulate gonadal tumorigenesis.
Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
[TBL] [Abstract][Full Text] [Related]
15. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice.
Matzuk MM; Finegold MJ; Mather JP; Krummen L; Lu H; Bradley A
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8817-21. PubMed ID: 8090730
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liver.
Gold EJ; O'Bryan MK; Mellor SL; Cranfield M; Risbridger GP; Groome NP; Fleming JS
Mol Cell Endocrinol; 2004 Jul; 222(1-2):61-9. PubMed ID: 15249126
[TBL] [Abstract][Full Text] [Related]
17. Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer.
Käufl SD; Kuhn C; Kunze S; Shabani N; Brüning A; Friese K; Mylonas I
Arch Gynecol Obstet; 2011 Jul; 284(1):199-207. PubMed ID: 20683603
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluating the role of activin-βC in cancer biology.
Marino FE; Risbridger G; Gold E
Cytokine Growth Factor Rev; 2015 Aug; 26(4):463-70. PubMed ID: 26058376
[TBL] [Abstract][Full Text] [Related]
19. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice.
Burns KH; Agno JE; Sicinski P; Matzuk MM
Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
